A composition for the promotion of alcohol and acetaldehyde degradation in a human is disclosed. The composition, which can be prepared by bringing all the ingredients together in intimate physical admixture, comprises an anti-hangover effective amount of: (a) essential herbs consisting of Ilex paraguarensis (Yerba mate), Eleutherococcus senticosus (Siberian ginseng), Panax ginseng and Zingiberis officinalis (ginger); and (b) one or more electrolyte(s) and, optionally, (c) sulphoraphane.

Preferably, the composition is in the form of a low-volume, aqueous, after-alcohol drink, that can avoid some of the potentially adverse effects of previously-known anti-hangover preparations.

A composition for the promotion of alcohol and acetaldehyde degradation in a human is disclosed. The composition, which can be prepared by bringing all the ingredients together in intimate physical admixture, comprises an anti-hangover effective amount of: (a) essential herbs consisting of Ilex paraguarensis (Yerba mate), Eleutherococcus senticosus (Siberian ginseng), Panax ginseng and Zingiberis officinalis (ginger); and (b) one or more electrolyte(s) and, optionally, (c) sulphoraphane.

Preferably, the composition is in the form of a low-volume, aqueous, after-alcohol drink, that can avoid some of the potentially adverse effects of previously-known anti-hangover preparations.

The present disclosure relates to a pharmaceutical composition for preventing or treating a cranial nerve disease, comprising a Fomes fomentarius extract, a fraction thereof, or a compound isolated therefrom as an active ingredient. According to the present disclosure, the Fomes fomentarius extract is included as an active ingredient so that there are significant effects of inhibiting the production or expression of inflammatory cytokines and improving the activity of glucose metabolism in the brain to prevent or treat cranial nerve diseases, of lowering side effects on the human body as a natural product, and of being easily prepared and ingested.

The present disclosure relates to a pharmaceutical composition for preventing or treating a cranial nerve disease, comprising a Fomes fomentarius extract, a fraction thereof, or a compound isolated therefrom as an active ingredient. According to the present disclosure, the Fomes fomentarius extract is included as an active ingredient so that there are significant effects of inhibiting the production or expression of inflammatory cytokines and improving the activity of glucose metabolism in the brain to prevent or treat cranial nerve diseases, of lowering side effects on the human body as a natural product, and of being easily prepared and ingested.

A pharmaceutical composition containing cannabis for increasing energy levels and/or alleviating fatigue in a patient. Also provided are a use of the pharmaceutical composition for increasing energy levels and/or alleviating fatigue in a patient, and methods for increasing energy levels and/or alleviating fatigue. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: cannabis, an herb, vitamins, and/or fructose.

A pharmaceutical composition containing cannabis for increasing energy levels and/or alleviating fatigue in a patient. Also provided are a use of the pharmaceutical composition for increasing energy levels and/or alleviating fatigue in a patient, and methods for increasing energy levels and/or alleviating fatigue. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: cannabis, an herb, vitamins, and/or fructose.

A topical composition comprising an extract of Allium species, an extract of Citrus species, an extract of Paullinia species and an extract of Theobroma species is used for improving and/or increasing and/or stimulating and/or promoting and/or inducing the pigmentation of hair and/or hairs.

A topical composition comprising an extract of Allium species, an extract of Citrus species, an extract of Paullinia species and an extract of Theobroma species is used for improving and/or increasing and/or stimulating and/or promoting and/or inducing the pigmentation of hair and/or hairs.

The present disclosure provides a method for increasing content of melatonin in a subject and regulating expression of TPH gene, DDC gene, AANAT gene, and ASMT gene, including administering to a subject in need thereof a composition comprising an effective amount of a longan flower extract, wherein the longan flower extract can effectively increase the content of melatonin in the subject, and can directly improve sleep disturbance and insomnia, as well as the sleep quality within a few days after taking the longan flower extract. The present disclosure can help activate the melatonin synthesis pathway.

The present disclosure provides a method for increasing content of melatonin in a subject and regulating expression of TPH gene, DDC gene, AANAT gene, and ASMT gene, including administering to a subject in need thereof a composition comprising an effective amount of a longan flower extract, wherein the longan flower extract can effectively increase the content of melatonin in the subject, and can directly improve sleep disturbance and insomnia, as well as the sleep quality within a few days after taking the longan flower extract. The present disclosure can help activate the melatonin synthesis pathway.